Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

clarkhealthcommunications

- PMLiVE

UK and EU’s future relationship ‘must protect patients’

UK coalition concerned about regulation, data sharing, infectious disease controls

- PMLiVE

Behaviour change – a missing ingredient?

‘Successful and impactful behaviour change requires huge commitment and time’

Porterhouse Medical is raising awareness for pancreatic cancer, here’s why…

Porterhouse Medical Group

- PMLiVE

Fishawack launches two new divisions, Life partners with hygiene charity and ROAD wins new account

Healthcare comms news round-up

Roche Basel Switzerland

Roche builds on Immunocore ImmTAC deal

Extends partnership to target MAGE-A4 protein tumours

- PMLiVE

CHMP backs Sanofi’s all-oral sleeping sickness drug

Sanofi's drug and others given green light by EMA committee

- PMLiVE

Roche pulls EU Tecentriq/Avastin filing in kidney cancer

Another setback for Roche, but CHMP changes its mind on Opdivo/Yervoy

- PMLiVE

Behaviour change: what is the buzz all about?

'The value of behavioural sciences is only fully realised when it is integrated into a broader communications strategy and tactical mix’

Fishawack launches new website and introduces new structure for growth

The Fishawack Group has launched their new website, introducing the company’s new two-division structure, Fishawack Medical Communications and Fishawack Creative. The new site showcases the Group's capabilities as well as...

Avalere Health

- PMLiVE

Orphan drugs from Biogen and Amicus win UK Prix Galien

New medical technology category added for the first time

- PMLiVE

UniQure skyrockets on haemophilia B gene therapy data

Competition with Pfizer and Spark rival heats up

- PMLiVE

AZ’s MYSTIC survival data is in – and it’s a bust

Imfinzi failed to achieve OS improvement

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links